Arango 2012
Methods | Quasi-RCT: alternate allocation to AQ+SP and AQ+SP+PQ, then MQ+AS and MQ+AS+PQ | |
Participants | Inclusion criteria: 1. Uncomplicated malaria 2. Pf only 3. Not pregnant 4. Voluntary consent Colombia 82 patients, aged one to 75 years (mean age ranged from 24 to 35 years in four groups) Gametocytes in 23/82 (28%) | |
Interventions | All loose combinations: 1. AQ+SP 2. AQ+SP+PQ 3. MQ+AS 4. MQ+AS+PQ AQ: 25 mg/kg total dose divided into 10 mg/kg on day 1 and 7.5 mg/kg on days 2 and 3 SP: 25 mg/kg/1.25 mg/kg single dose on day 1 MQ: 25 mg/kg total dose, divided into 8.3 mg/kg per day for 3 days AS: 4 mg/kg per day for 3 days PQ: 0.75 mg/kg, total single dose on day 2 | |
Outcomes | Day 1 (pretreatment with schizonticide), 4 and 8 Asexual and gametocyte counts in thick smears Gametocyte prevalence Gametocyte density | |
Notes | No mention of G6PD status | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Alternate allocation. |
Allocation concealment (selection bias) | Unclear risk | Not discussed. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No evidence of incomplete data. |
Selective reporting (reporting bias) | Low risk | No evidence of selective reporting. |
Other bias | Unclear risk | Nothing obvious. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not discussed. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not discussed. |